Connecting the World to Startups Transforming Healthcare
We are next generation impact investors democratizing access to private healthcare companies tackling some of humanities biggest challenges. Our investment thesis is focused around the convergence of bio + tech. We see this convergence as our a blueprint for innovation.
The Age of Biology
The convergence of bio + tech is making things more accessible, personalized, cheaper, and faster. We provides access to highly vetted healthcare startups changing the world with high return potential. We don't invest in moonshots. We invest in the rebel scientists, the visionaries pushing the boundaries to find solutions to complex problems that are market ready or nearly there.
Founders in our portfolio gain access to the Bioverge Network, an expansive web of investors, subject matter experts, advisors, and others that are passionate about healthcare and driven to make a difference.
Discover. Engage. Invest.
If you are interested in accessing our deal flow and engaging with our portfolio, we encourage you to back our syndicate and register at https:///bioverge.com.
- Sign up for our Newsletter: https://bioverge.com
- Follow us on Twitter: https://twitter.com/biovergehq
- Follow us on Medium: https://medium.com/@bioverge
Please note: angel investing in technology startups is risky. There is a meaningful chance that a company will fail and return no money back to investors. Even with a successful company, investors should be prepared to have their capital committed for up to 10 years without liquidity.
Bioverge deals are highly curated. We syndicate our deal flow through AngelList when it's appropriate for the founders we are supporting.